These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34805856)

  • 1. Enterprise stent for symptomatic complex intracranial atherosclerotic stenosis: safety and efficiency.
    Dong Y; Liu C; Li D; Chen Z; Sun X; Guan S
    J Interv Med; 2018 Nov; 1(4):234-239. PubMed ID: 34805856
    [No Abstract]   [Full Text] [Related]  

  • 2. Medium-term results of undersized angioplasty and stenting for symptomatic high-grade intracranial atherosclerotic stenosis with Enterprise.
    Salik AE; Selcuk HH; Zalov H; Kilinc F; Cirak M; Kara B
    Interv Neuroradiol; 2019 Oct; 25(5):484-490. PubMed ID: 30991867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A long-term follow-up results of Enterprise stent in treatment of severe symptomatic basilar artery atherosclerotic stenosis].
    Zhao Y; Jin M; Liu Q; Liu D; Chen J; Du B
    Zhonghua Nei Ke Za Zhi; 2016 May; 55(5):372-6. PubMed ID: 27143187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term outcome of stenting with Enterprise stents for symptomatic intracranial atherosclerotic disease at a single center.
    Li A; Ye Z; Zhou W; Qin C
    Interv Neuroradiol; 2023 Dec; 29(6):731-737. PubMed ID: 36259331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterprise stent for the treatment of symptomatic intracranial atherosclerotic stenosis: an initial experience of 44 patients.
    Feng Z; Duan G; Zhang P; Chen L; Xu Y; Hong B; Zhao W; Liu J; Huang Q
    BMC Neurol; 2015 Oct; 15():187. PubMed ID: 26449986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Undersized angioplasty and stenting of symptomatic intracranial tight stenosis with Enterprise: Evaluation of clinical and vascular outcome.
    Lee KY; Chen DY; Hsu HL; Chen CJ; Tseng YC
    Interv Neuroradiol; 2016 Apr; 22(2):187-95. PubMed ID: 26542728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endovascular treatment of symptomatic intracranial atherosclerotic stenosis with low profile visualized intraluminal support stent.
    Tang H; Lu Z; Zeng Z; Zuo Q; Li Q; Xu F; Huang Q; Liu J
    J Clin Neurosci; 2021 Aug; 90():256-261. PubMed ID: 34275559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting in-stent restenosis after angioplasty with the Enterprise stent for intracranial atherosclerotic diseases.
    Zhang K; Li TX; Wang ZL; Gao BL; Gu JJ; Gao HL; Wang YF; Xia JC
    Sci Rep; 2021 May; 11(1):10479. PubMed ID: 34006896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modified Bose method for the endovascular treatment of intracranial atherosclerotic arterial stenoses using the Enterprise stent.
    Vajda Z; Schmid E; Güthe T; Klötzsch C; Lindner A; Niehaus L; Sperber W; Peters J; Arnold G; Bäzner H; Henkes H
    Neurosurgery; 2012 Jan; 70(1):91-101; discussion 101. PubMed ID: 21778921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comparison of Stent Implant versus Medical Treatment for Severe Symptomatic Intracranial Stenosis: A Controlled Clinical Trial.
    Mohammadian R; Pashapour A; Sharifipour E; Mansourizadeh R; Mohammadian F; Taher Aghdam AA; Mousavi M; Dadras F
    Cerebrovasc Dis Extra; 2012 Jan; 2(1):108-20. PubMed ID: 23599702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the Enterprise Stent in Atherosclerotic Intracranial Arterial Stenosis: A Series of 60 Cases.
    Wang X; Wang Z; Wang C; Ji Y; Ding X; Zang Y
    Turk Neurosurg; 2016; 26(1):69-76. PubMed ID: 26768871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Application of Neuroform EZ stent in the treatment of severe intracranial arterial stenosis with complex symptomatic].
    Jia ZC; Bian HJ; Li X; Luan JY; Wang CM; Liu QJ; Han JT
    Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Oct; 51(5):835-839. PubMed ID: 31624386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial Angioplasty with Enterprise Stent for Intracranial Atherosclerotic Stenosis: A Single-Center Experience and a Systematic Review.
    Sun B; Xu C; Wu P; Li M; Xu S; Wang C; Liu X; Ling Y; Shi H
    Biomed Res Int; 2021; 2021():6645500. PubMed ID: 33959660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in China.
    Miao Z; Zhang Y; Shuai J; Jiang C; Zhu Q; Chen K; Liu L; Li B; Shi X; Gao L; Liu Y; Wang F; Li Y; Liu T; Zheng H; Wang Y; Wang Y;
    Stroke; 2015 Oct; 46(10):2822-9. PubMed ID: 26286544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary stent therapy for symptomatic intracranial atherosclerotic stenosis: 1-year follow-up angiographic and midterm clinical outcomes.
    Lee CY; Yim MB
    J Neurosurg; 2006 Aug; 105(2):235-41. PubMed ID: 17219828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease.
    Fiorella D; Chow MM; Anderson M; Woo H; Rasmussen PA; Masaryk TJ
    Neurosurgery; 2007 Aug; 61(2):236-42; discussion 242-3. PubMed ID: 17762735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stent design lowers angiographic but not clinical adverse events in stenting of symptomatic intracranial stenosis - results of a single center study with 100 consecutive patients.
    Rohde S; Seckinger J; Hähnel S; Ringleb PA; Bendszus M; Hartmann M
    Int J Stroke; 2013 Feb; 8(2):87-94. PubMed ID: 22296983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solitaire stents for the treatment of complex symptomatic intracranial stenosis after antithrombotic failure: safety and efficacy evaluation.
    Duan G; Feng Z; Zhang L; Zhang P; Chen L; Hong B; Xu Y; Zhao W; Liu J; Huang Q
    J Neurointerv Surg; 2016 Jul; 8(7):680-4. PubMed ID: 26041096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic intracranial vertebral artery atherosclerotic stenosis (≥70%) with concurrent contralateral vertebral atherosclerotic diseases in 88 patients treated with the intracranial stenting.
    Wang ZL; Gao BL; Li TX; Cai DY; Zhu LF; Bai WX; Xue JY; Li ZS
    Eur J Radiol; 2015 Sep; 84(9):1801-4. PubMed ID: 26119803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of intracranial in-stent restenoses: predilatation with a drug eluting balloon, followed by the deployment of a self-expanding stent.
    Vajda Z; Güthe T; Perez MA; Kurre W; Schmid E; Bäzner H; Henkes H
    Cardiovasc Intervent Radiol; 2013 Apr; 36(2):346-52. PubMed ID: 22869043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.